(NewsGlobal.com)- One of the top advisors to President Joe Biden still hasn’t divested the investment portfolio her and her husband have, which totals into the tens of millions of dollars.
The Washington Examiner reported this week that Dunn disclosed that she and her husband owned between $16.8 million to $48.2 million in call options, bonds and stocks for the 2021 financial disclosure. About a week after that news came out, in mid-August, a spokesman for the White House told the Daily Caller News Foundation that she would divest herself from the portfolio so she could avoid conflicts of interest.
At the time, the spokesman said she was “still in the process” of doing that. The official further said Dunn is “taking all necessary steps” and “has the appropriate recusals in place” as she’s doing so.
Part of that recusal is that Dunn hasn’t be a part of working with any of her former clients that she worked with at SKDK, a public affairs consulting firm.
In the disclosure she and her husband filed, Dunn said they own bonds that are issued by Wells Fargo, Apple, Visa and Amazon. They also own a wide selection of stocks, including as much as $15,000 worth of shares from CVS, General Dynamics, Coca-Cola and Pfizer.
Dunn’s husband is Bob Bauer, who served as a White House counsel during the Obama administration.
The problem is that Dunn still hasn’t completely divested herself of the portfolio she promised to do, now almost a month after the fact.
Michael Chamberlain, who serves as the director of ethics at the watchdog group Protect the Public’s Trust, recently commented to DCNF:
“This episode is emblematic of the administration’s broken promises when it comes to ethics and transparency. Anita Dunn represents the epitome of the revolving door that engenders mistrust in government among the American public.”
Dunn served as an adviser during Biden’s transition team back in 2019. She joined the administration as a full-time adviser back in April.
Chamberlain commented that officials in “limited circumstances” could get as many as 180 days to divest themselves from holdings. However, he said that since it’s not Dunn’s first go-around serving with Biden, it showed that there are potential conflicts of interest that have been in place for a while now.
As he explained:
“They were present during her previous tenure, but her role was carefully crafted to avoid disclosure and divestiture at all costs.”
The DCNF further reported that some of the companies that Dunn consulted for while working at SKDK have either stood to, or actually did, benefit from various forms of federal funding.
Two of the companies that fit into this box are Pfizer, which has been one of the leading pharmaceutical companies at the heart of creating drugs and vaccines during the COVID-19 pandemic; and Micron, which could benefit from the new CHIPS Plus Act that will dedicate $52 billion to boost domestic manufacturing of computer chips.